We are live on
!
Find out more
BE
Bonness Enterprises Portfolio holdings
AUM
$310M
1-Year Est. Return
24.22%
This Fund
S&P 500
This Quarter
Est. Return
+11.16%
1 Year Est. Return
+24.22%
3 Year Est. Return
+94.56%
5 Year Est. Return
+137.52%
10 Year Est. Return
+441.57%
AUM
$239M
AUM Growth
+$20.8M
(+9.5%)
Cap. Flow
-$1.76M
Cap. Flow
% of AUM
-0.74%
Top 10 Holdings %
Top 10 Hldgs %
72.21%
Holding
40
New
–
Increased
4
Reduced
5
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Corning
GLW
|
+$855K |
| 2 |
Pfizer
PFE
|
+$151K |
| 3 |
Verizon
VZ
|
+$65.2K |
| 4 |
AT&T
T
|
+$47.4K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Aerospace
GE
|
+$1.12M |
| 2 |
Organon & Co
OGN
|
+$866K |
| 3 |
Stryker
SYK
|
+$347K |
| 4 |
GE HealthCare
GEHC
|
+$274K |
| 5 |
Applied Materials
AMAT
|
+$147K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 41.01% |
| 2 | Healthcare | 25.71% |
| 3 | Technology | 22.5% |
| 4 | Consumer Staples | 3.28% |
| 5 | Industrials | 2.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Progressive
PGR
$122B
| $90.4M | 37.83% |
567,757
| – | – |
|
|
2
Stryker
SYK
$128B
| $19.7M | 8.25% |
65,894
-1,236
| -2% | -$347K |
|
3
Microsoft
MSFT
$3.59T
| $15.4M | 6.43% |
40,900
| – | – |
|
4
Apple
AAPL
$4.48T
| $10.5M | 4.38% |
54,440
-500
| -0.9% | -$92.3K |
|
5
Merck
MRK
$317B
| $7.58M | 3.17% |
69,500
| – | – |
|
6
Intel
INTC
$457B
| $6.48M | 2.71% |
129,050
-900
| -0.7% | -$36.6K |
|
7
Johnson & Johnson
JNJ
$609B
| $6.09M | 2.55% |
38,838
| – | – |
|
8
Thermo Fisher Scientific
TMO
$214B
| $5.83M | 2.44% |
10,985
| – | – |
|
9
AbbVie
ABBV
$435B
| $5.72M | 2.39% |
36,900
| – | – |
|
|
10
Applied Materials
AMAT
$408B
| $4.91M | 2.05% |
30,300
-1,000
| -3% | -$147K |
|
11
IBM
IBM
$213B
| $4.84M | 2.02% |
29,564
| – | – |
|
|
MRSH
12
Marsh
MRSH
$91.4B
| $4.83M | 2.02% |
25,500
| – | – |
|
13
Nucor
NUE
$58.5B
| $4.77M | 2% |
27,435
| – | – |
|
14
Emerson Electric
EMR
$85.4B
| $4.19M | 1.75% |
43,000
| – | – |
|
15
Cisco
CSCO
$455B
| $4.18M | 1.75% |
82,700
| – | – |
|
16
Unilever
UL
$137B
| $3.69M | 1.54% |
67,591
| – | – |
|
17
Abbott
ABT
$185B
| $3.6M | 1.51% |
32,700
| – | – |
|
|
18
Pfizer
PFE
$143B
| $3.3M | 1.38% |
114,708
+5,000
| +5% | +$151K |
|
19
Bristol-Myers Squibb
BMY
$133B
| $2.79M | 1.17% |
54,300
| – | – |
|
|
20
Corning
GLW
$124B
| $2.63M | 1.1% |
86,300
+29,900
| +53% | +$855K |
|
21
Agilent Technologies
A
$39.2B
| $2.49M | 1.04% |
17,900
| – | – |
|
22
Procter & Gamble
PG
$337B
| $2.4M | 1.01% |
16,400
| – | – |
|
23
Philips
PHG
$25.6B
| $2.37M | 0.99% |
113,544
| – | – |
|
24
United Parcel Service
UPS
$90.6B
| $2.35M | 0.98% |
14,950
| – | – |
|
25
GSK
GSK
$103B
| $1.96M | 0.82% |
52,960
| – | – |
|
Similar funds
IPW
TL
RGC
IR
TWM
PH
CCG
FI
Bonness Enterprises's Q4 2023 Portfolio in Review
As of Q4 2023, Bonness Enterprises held 40 positions worth $239M, up 9.5% from $218M the previous quarter. Its ten largest holdings account for 72% of the portfolio.
Bonness Enterprises's Q4 2023 filing shows 4 increased, 5 reduced and 2 closed positions. The largest sale was GE Aerospace, an estimated $1.12M.
By sector, the portfolio is most concentrated in Financials at 41% of assets, up from 40% a quarter earlier, followed by Healthcare and Technology.
- Bonness Enterprises added most to Corning in Q4 2023, an estimated $855K increase.
- Bonness Enterprises's biggest Q4 2023 reduction was GE Aerospace, cutting an estimated $1.12M.
- Bonness Enterprises fully exited Organon & Co in Q4 2023, selling an estimated $866K.
- Bonness Enterprises's ten largest holdings make up 72% of its $239M portfolio in Q4 2023.
- Bonness Enterprises opened 0 new positions and closed 2 in Q4 2023.
- Bonness Enterprises's portfolio value rose 9.5% quarter-over-quarter to $239M.
Based on Bonness Enterprises's 13F filing for Q4 2023, filed 22 Jan 2024.